1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: G-PCNSL-SG1, NCT00153530
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006-003750-23, LINFOTARGAM, NCT00466258
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
|
|
5.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Under 46
Sponsor: Other
Protocol IDs: UMN-MT-1995-06, UMN-9224, UMN-MT-9506, NCI-V00-1605, NCT00006451
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000068525, EORTC-GU-30986, NCT00014274
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1583
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8223/24/25, SWOG-8224, SWOG-8225
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: NCI-76-C-377A, NCI-MB-160A
|
|
14.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-76-C-377B, NCI-MB-160B
|
|
15.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 10 to 65
Sponsor: NCI
Protocol IDs: NCI-80-C-45, NCI-SB-S9, NCI-T83-1103N, T83-1103
|
|
16.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-100
|
|
17.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NBCG-14
|
|
18.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UCCRC-3248, NCI-D81-014-080
|
|
19.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-013-686
|
|
20.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and under
Sponsor:
Protocol IDs: CHOP-204
|
|
21.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 25 to 65
Sponsor:
Protocol IDs: DFCI-75116
|
|
22.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
|
|
23.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DFCI-83084, NCI-T84-0282D, T84-0282
|
|
24.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: physiologic 70 and under
Sponsor: NCI
Protocol IDs: RPMI-PPC-744, NCI-T83-0960D
|
|
25.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096
|
Mobile | Español
